Key result
Post-procedural pericardial effusion occurred in 10% of patients undergoing heart rhythm device implantation, with female gender significantly increasing the risk of any effusion (HR 2.7).
Why the study?
What are the incidence and predictors of pericardial effusion in patients undergoing permanent heart rhythm device implantation?
Population
968 consecutive patients undergoing permanent heart rhythm device implantation or upgrade.
Design
Cohort
Follow-up
3.1±0.5 months
Authors
Loading...
May support closer post-implant surveillance in women; observational data leaves open causal mechanisms and prevention trials.
Observational (n=968)
No
What are the incidence and predictors of pericardial effusion in patients undergoing permanent heart rhythm device implantation?
Hazard Ratio: 2.7 (95% CI 1.4–3.5)
p-value: p=0.01
Pericardial effusion is a relatively common (10%) complication after heart rhythm device implantation but rarely requires intervention, with female gender and antiplatelet use identified as key risk factors.
Ohlow et al. (2012) conducted an observational in Heart rhythm device implantation (n=968). Female gender vs. Male gender was evaluated on Any post-procedural pericardial effusion (HR 2.7, 95% CI 1.4-3.5, p=0.01). Post-procedural pericardial effusion occurred in 10% of patients undergoing heart rhythm device implantation, with female gender significantly increasing the risk of any effusion (HR 2.7).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: